Medicamen Biotech Ltd

Growth Ratio Summary

Growth Score : 4.80

The company's revenue and asset growth are positive, but its operating profit, earnings per share, and net income are declining. While revenue and assets are increasing, profitability is decreasing. This is a point of concern for the company. The company needs to improve on its profitability.

Financial Ratio Summary

Financial Score : 4.00

The company shows mixed financial performance. While capital expenditure is well-managed, there are concerns regarding earnings per share and book value. Dividend payments are sustainable, but there's room for improvement in overall financial management. The company needs to improve on its financial management.

Profitability Ratio Summary

Profitability Score : 9.60

The company demonstrates strong profitability. The company generates healthy profits from its sales, assets, and capital employed. This indicates that the company is effectively managing its costs and generating strong returns for its investors. The company is in a good position to generate profits.

Efficiency Ratio Summary

Efficiency Score : 2.33

The company is not effectively utilizing its assets to generate revenue. Its fixed assets, inventory, receivables, and capital are not being efficiently converted into sales. This can lead to lost revenue opportunities and increased carrying costs. This is a point of concern for the company. This may affect the company's profitability.

Coverage Ratio Summary

Coverage Score : 8.80

The company has a good ability to meet its interest and dividend payments. It's generating sufficient earnings to cover its interest expenses, and it has a comfortable cushion to pay dividends to its shareholders. This is a positive sign for the company. The company is doing well in terms of coverage.

Solvency Ratio Summary

Solvency Score : 10.00

The company exhibits very strong long-term financial stability. The company has a very low level of debt relative to its equity and assets. This suggests that the company relies more on equity than debt to finance its operations. A high equity ratio further confirms this financial strength. The company is in a very stable position for its long term liablities.

Liquidity Ratio Summary

Liquidity Score : 6.64

The company shows a satisfactory ability to meet its short-term obligations. A positive aspect is its ability to quickly convert assets into cash. However, its cash holdings are relatively low, and operating cash flow is negative, which could pose challenges in the short term. The healthcare industry's specific working capital requirements might influence these ratios. Further analysis is needed to determine if the current liquidity position is sufficient for operational needs.